Results 151 to 160 of about 4,933 (206)

Trihexyphenidyl (Artane) abuse in schizophrenic patients

International Clinical Psychopharmacology, 1996
Trihexyphenidyl (THP) and other anticholinergics are liable to abuse by schizophrenic patients. Data concerning the incidence and characteristics of the abusers are scarce. In the present study an evaluation of 214 consecutive admissions of schizophrenic patients revealed 14 THP abusers, an incidence of 6.5%.
Z Weiner, Abraham Weizman, Zvi Zemishlany, Dov Aizenberg   +3 more
openaire   +3 more sources

Use of Trihexyphenidyl in Children With Cerebral Palsy

Pediatric Neurology, 2011
A paucity of information exists regarding medications to treat dystonia in children with cerebral palsy. This study sought to review the benefits and tolerability of trihexyphenidyl in children with cerebral palsy, treated for dystonia or sialorrhea or both in a pediatric tertiary care hospital, through a retrospective chart review.
Alison Moore, Alison Moore, Mauricio R. Delgado, Mauricio R. Delgado, Jorge Carranza-del Rio, Jorge Carranza-del Rio, Nancy J. Clegg   +6 more
openaire   +3 more sources

Neuroendocrine Response to Trihexyphenidyl in Depressed Patients

Clinical Neuropharmacology, 1992
The effect of a single dose (10 mg P.O.) of trihexyphenidyl (THP) on plasma cortisol, growth hormone (GH), and immunoreactive beta-endorphin (ir-beta-EP) was studied in seven major depressed patients and seven controls. GH secretion was suppressed (34-41%) by THP in both groups.
Alan Apter, Irit Gil-Ad, Avi Valevski, Abraham Weizman, Samuel Tyano, Zvi Laron, Ilan Modai   +6 more
openaire   +2 more sources

Physiostigmine and trihexyphenidyl toxic psychosis

Nordisk Psykiatrisk Tidsskrift, 1984
Melvin McInnis, a recent graduate from the University of Iceland, is presently a registrar in psychiatry at the Department of Psychiatry, Borgarspitalinn. Research interests include studies of dependence liability and long-term efficacy of antiparkinsonian drugs.Hannes Petursson is head of the Department of Psychiatry at Borgarspitalinn.
M. Mcinnis, H. Petursson
openaire   +2 more sources

Treatment of Negative Schizophrenic Symptoms with Trihexyphenidyl

Journal of Clinical Psychopharmacology, 1988
In an effort to investigate reports of possible benefits of trihexyphenidyl on residual schizophrenic symptoms, the drug was administered to five chronic schizophrenic patients with predominantly negative symptoms. These patients were simultaneously receiving various antipsychotic agents without extrapyramidal side effects.
Kenneth R. Silk, Rajiv Tandon, John F. Greden   +2 more
openaire   +3 more sources

TRIHEXYPHENIDYL (ARTANE®), STRAMONIUM, AND NONCHEMOTHERAPY OF PARALYSIS AGITANS

Archives of Neurology And Psychiatry, 1952
SINCE the use of scopolamine by Gnauck1in 1882 in cases of paralysis agitans, an unknown number of chemotherapies have been studied.2None has been effective in arresting or reversing the course of the disorder. At best, a few have been considered relatively effective in relieving some of the more distressing symptoms in some patients.
Emil Alvermann, Bernard Berkowitz
openaire   +3 more sources

Comparison of Effectiveness and Tolerability of Clonidine and Trihexyphenidyl in Clozapine-Induced Hypersalivation

Journal of Clinical Psychopharmacology
Purpose/Background Clozapine-induced hypersalivation is one of the most common bothersome adverse reactions of clozapine. The management strategies for this condition remain inadequately studied and understood.
Puangpet Pansawat, Wattanapong Pansawat, Sipanut Silaket, T. Supapaan, Tuanthon Boonlue   +4 more
semanticscholar   +1 more source

Holmes Tremors in a 60-year-old Woman Following Primary Brainstem hemorrhage (PBH) Responsive to Standard Dose of Trihexyphenidyl: A case report and literature review

Journal Africain des Cas Cliniques et Revues
Introduction: The Holmes tremor, once known as rubral or mesencephalic tremor, is an uncommon and atypical condition that presents as an irregular resting tremor, often accompanied by an action tremor that worsens with certain postures.
G. Chubaka-Magala, É. Aka-Anghui Diarra, Sac Agbo-Panzo, PT Folatet, Ant Essoin, Cvcak Kadjo, FD Offoumou, M. Amon-Tanoh, AC Tanoh, C. Yapo-Ehounoud, M. Doumbia-Ouattara, A. Berthe   +11 more
semanticscholar   +1 more source

Trihexyphenidyl treatment of clozapine-induced hypersalivation

International Clinical Psychopharmacology, 1997
The objective of this study was to investigate the efficacy of the anticholinergic agent trihexyphenidyl in the treatment of clozapine-induced hypersalivation. Fourteen chronic schizophrenic patients who exhibited nocturnal hypersalivation during clozapine treatment were coadministered trihexyphenidyl (5-15 mg/day, at bedtime) for 15 days.
Abraham Weizman, L Rosen, Roberto Mester, B. Spivak, Simona Adlersberg, N Gonen   +5 more
openaire   +3 more sources

Trihexyphenidyl (Artane) Abuse: Euphoriant and Anxiolytic

British Journal of Psychiatry, 1982
Trihexyphenidyl (benzhexol, Artane) is an anticholinergic drug widely used among the psychiatric population in order to control extrapyramidal symptoms from the use of anti-psychotic drugs. In addition to the many well-known somatic and psychiatric side effects caused by the drug (Shader and Greenblatt, 1971), including toxic psychosis, trihexyphenidyl
Yifrah Kaminer, Hanan Munitz, H. Wijsenbeek   +2 more
openaire   +3 more sources